Recently, CPZ was shown to reduce the levels of CALM protein in a concentration-dependent manner, thereby altering the cellular localization of RTKs with AML-associated mutations, without disturbing wild-type RTKs (Figure 5B (iv)) [147]. The gene discussed is CPZ; the disease is acute myeloid leukemia.